As previously shown, cardiomyopathy associated RBM20 mutations lead to a missplicing of several cardiac genes, including TTN and RYR2. Recently, we have established a qRT-PCR-based splicing assay using explanted myocardial tissue to predict the pathogenic impact of RBM20 mutations [10]. This evidence concerns the gene RYR2 and cardiomyopathy.